menu search

CYBN / Cybin, Deepak Chopra Announce Partnership For Psychedelics Awareness And Education

Psychedelics-focused biotech company Cybin Inc. (NYSE:CYBN) announced that it has formed a partnership with The Chopra Foundation, a not-for-profit founded by alternative medicine and new age author Deepak Chopra. "The Foundation is working closely with Cybin to support education and awareness about its groundbreaking research to harness the potential of psychedelic therapies in mental health,” the organization stated in a press release. Read More
Posted: Feb 15 2022, 21:09
Author Name: Benzinga
Views: 111682

CYBN News  

Cybin to Participate in the Cantor Global Healthcare Conference

By Business Wire
September 25, 2023

Cybin to Participate in the Cantor Global Healthcare Conference

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company co more_horizontal

Cybin Announces Date of Annual and Special Meeting of Shareholders

By Business Wire
September 21, 2023

Cybin Announces Date of Annual and Special Meeting of Shareholders

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company co more_horizontal

Cybin shares continue to rise on major investment from Steve Cohen's hedge fund

By Proactive Investors
September 20, 2023

Cybin shares continue to rise on major investment from Steve Cohen's hedge fund

Cybin Inc. (NYSE-A:CYBN, NEO:CYBN) shares maintained upward momentum on Wednesday after soaring earlier this week on the news New York Mets owner Stev more_horizontal

Psychedelic stock jumps as Steve Cohen's Point72 snaps up shares

By Market Watch
September 18, 2023

Psychedelic stock jumps as Steve Cohen's Point72 snaps up shares

Shares of Cybin Inc., CYBN, +39.39% a developer of psychedelic therapies, finished 38.5% higher on Monday after billionaire investor and New York Mets more_horizontal

The 3 Most Undervalued Under-$1 Stocks to Buy in September 2023

By InvestorPlace
September 14, 2023

The 3 Most Undervalued Under-$1 Stocks to Buy in September 2023

The global inflation surge and monetary policy tightening by major central banks have all contributed to the market volatility this year. Despite that more_horizontal

Cybin narrows net loss year-over-year; eyes FDA submission in late 2023

By Proactive Investors
June 29, 2023

Cybin narrows net loss year-over-year; eyes FDA submission in late 2023

Cybin Inc. (NYSE-A:CYBN, NEO:CYBN) reported that it has narrowed its net loss year-over-year as it has advanced its two lead clinical programs CYB003 more_horizontal

Best Penny Stocks to Buy Under $1? 4 To Watch Now

By PennyStocks
June 15, 2023

Best Penny Stocks to Buy Under $1? 4 To Watch Now

Ever find yourself daydreaming about striking it rich in the stock market? Well, buckle up, because we're about to dive headfirst into the world of pe more_horizontal

Cybin shares rise as 3Q results meet expectations, analysts maintain ‘positive bias outlook'

By Proactive Investors
February 15, 2023

Cybin shares rise as 3Q results meet expectations, analysts maintain ‘positive bias outlook'

Cybin Inc. (NYSE-A:CYBN, NEO:CYBN) shares moved higher just after the market opened on Wednesday after the psychedelics-focused biopharmaceutical c more_horizontal


Search within

Pages Search Results: